Dergi
/
İmmünoloji ve Enfeksiyon
/
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
JoVE Journal
İmmünoloji ve Enfeksiyon
This content is Free Access.
JoVE Journal İmmünoloji ve Enfeksiyon
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

11,019 Views

•

12:43 min

•

January 06, 2014

DOI:

10.3791/50561-v

DOI:
10.3791/50561-v

•

12:43 min
January 06, 2014

•

3 Views
, , , , , , , , ,
1Cerrahi Bölümü,University of Michigan, 2İç Hastalıkları Anabilim Dalı,University of Michigan, 3Department of Otolaryngology,University of Michigan

Özet

Automatically generated

Evaluated in syngeneic immunocompetent hosts, cancer stem cell (CSC) based dendritic cell (DC) vaccine demonstrated significantly higher antitumor immunity than traditional DC vaccines pulsed with heterogeneous bulk tumor cells.

Explore More Videos

Cancer Stem CellsDendritic Cell VaccineMelanomaSquamous CancerALDHAntitumor ImmunityIFN-γGM-CSF

Read Article

Cite this Article

Li, Q., Lu, L., Tao, H., Xue, C., Teitz-Tennenbaum, S., Owen, J. H., Moyer, J. S., Prince, M. E., Chang, A. E., Wicha, M. S. Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells. J. Vis. Exp. (83), e50561, doi:10.3791/50561 (2014).

Download .ris file

Copy

Share Video

.

Copy